ACETYLCYSTEINE ZIDRIMER
UNII 7JWF1EYH61

Substance Identification & Data

This profile provides standardized clinical and technical data for Acetylcysteine Zidrimer, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7JWF1EYH61.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2736440-65-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7JWF1EYH61

CAS Registry Number

2736440-65-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ACETYLCYSTEINE ZIDRIMER

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190359

National Cancer Institute reference terminology for clinical and research data.

INN ID

12597

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-211

Identifier assigned by the United States Adopted Names Council.

Substance Type

polymer

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Acetylcysteine Zidrimer. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ACETYLCYSTEINE ZIDRIMER

Common Names & Synonyms

ACETYLCYSTEINE ZIDRIMER [INN]

ACETYLCYSTEINE ZIDRIMER [USAN]

L-ALANINE, N-ACETYL-S-((3-((2,5-DIOXO-1-PYRROLIDINYL)OXY)-3-OXOPROPYL)DITHIO)-, REACTION PRODUCTS WITH 4-(((1,1-DIMETHYLETHOXY)CARBONYL)AMINO)BUTANOIC ACID, ETHANOLAMINE AND ETHYLENEDIAMINE-ME ACRYLATE POLYMER

N-ACETYL-L-CYSTEINE CONJUGATE WITH REGULAR DENDRIMER

N-ACETYL-L-CYSTEINE CONJUGATE WITH REGULAR DENDRIMER .ALPHA.,.ALPHA.',.ALPHA.'',.ALPHA.'''-(ETHANE-1,2-DIYLDINITRILO)TETRAKIS(.OMEGA.-HEXADECAKIS(3-((2-HYDROXYETHYL)AMINO)-3-OXOPROPYL)-DENDROG4-((3-OXOPROPANE-1,3-DIYL)AZANEDIYLETHYLENENITRILO)) WITH ABOUT 31% OF HYDROXY GROUPS SUBSTITUTED WITH 4-(3-((N-ACETYL-L-CYSTEIN-S-YL)SULFANYL)PROPANAMIDO)BUTANOYL GROUP

OP 101 [WHO-DD]